A phase 1 clinical trial of vorinostat in combination with decitabine in patients with acute myeloid leukaemia or myelodysplastic syndrome
2014 ◽
Vol 167
(2)
◽
pp. 185-193
◽
Keyword(s):
Phase 1
◽